Abstract
Bacterial genetic properties can be readily altered by a range of techniques, for example, when a mixture of recipient bacteria, donor genes, and nano-sized acicular material are stimulated by sliding friction on surface of the hydrogel such as agarose or gellan gum. In this particular case, a phenomenon called the Yoshida effect is responsible. Specially designed apparatus has been developed to investigate this effect in an effort to identify technical applications, such as the quantitative detection of asbestos. Current patents related to plasmid transformation methods for prokaryotes and quantitative detection of environmental asbestos are also presented.
Keywords: Yoshida effect, asbestos, chrysotile, hydrogel, sepiolite, plasmid, prokaryote, sliding friction, transformation
Recent Patents on Biotechnology
Title: Discovery and Application of the Yoshida Effect: Nano-Sized Acicular Materials Enable Penetration of Bacterial Cells by Sliding Friction Force
Volume: 1 Issue: 3
Author(s): Naoto Yoshida
Affiliation:
Keywords: Yoshida effect, asbestos, chrysotile, hydrogel, sepiolite, plasmid, prokaryote, sliding friction, transformation
Abstract: Bacterial genetic properties can be readily altered by a range of techniques, for example, when a mixture of recipient bacteria, donor genes, and nano-sized acicular material are stimulated by sliding friction on surface of the hydrogel such as agarose or gellan gum. In this particular case, a phenomenon called the Yoshida effect is responsible. Specially designed apparatus has been developed to investigate this effect in an effort to identify technical applications, such as the quantitative detection of asbestos. Current patents related to plasmid transformation methods for prokaryotes and quantitative detection of environmental asbestos are also presented.
Export Options
About this article
Cite this article as:
Yoshida Naoto, Discovery and Application of the Yoshida Effect: Nano-Sized Acicular Materials Enable Penetration of Bacterial Cells by Sliding Friction Force, Recent Patents on Biotechnology 2007; 1 (3) . https://dx.doi.org/10.2174/187220807782330147
DOI https://dx.doi.org/10.2174/187220807782330147 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib
Current Pharmaceutical Design Role of Copper in Angiogenesis and Its Medicinal Implications
Current Medicinal Chemistry Aurora A and B Kinases - Targets of Novel Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery Flavonoid-Based Cancer Therapy: An Updated Review
Anti-Cancer Agents in Medicinal Chemistry Aptamers: Molecular Tools for Medical Diagnosis
Current Topics in Medicinal Chemistry Neurochemical Markers in the Mammalian Brain: Structure, Roles in Synaptic Communication, and Pharmacological Relevance
Current Medicinal Chemistry Immune Cell-derived Vesicles: Modulators and Mediators of Inflammation
Current Pharmaceutical Design Specific Targeted Therapy: A New Tool for the Destruction of Cancer
Current Drug Therapy Computational & Statistical Methodologies to Identify Biomarkers in Cancer
Current Cancer Therapy Reviews Recent Advances in Antabuse (Disulfiram): The Importance of its Metal-binding Ability to its Anticancer Activity
Current Medicinal Chemistry Chemical Space of FLT3 Inhibitors as Potential Anti-AML Drugs
Recent Patents on Anti-Cancer Drug Discovery The Development of New Concepts for Assessing Reproductive Toxicity Applicable to Large Scale Toxicological Programmes
Current Pharmaceutical Design Editorial: New Strategies and Applications for Drugs Targeting EGFR and c-Met
Current Drug Targets Metallodrugs in Targeted Cancer Therapeutics: Aiming at Chemoresistance- related Patterns and Immunosuppressive Tumor Networks
Current Medicinal Chemistry Amino Acid Degrading Enzymes and their Application in Cancer Therapy
Current Medicinal Chemistry Determination of Human Serum α1-Acid Glycoprotein and Albumin Binding of Various Marketed and Preclinical Kinase Inhibitors
Current Medicinal Chemistry Immune Checkpoints Aberrations and Malignant Mesothelioma: Assessment of Prognostic Value and Evaluation of Therapeutic Potentials
Anti-Cancer Agents in Medicinal Chemistry Epidemiology and Pathology of Malignant Mesothelioma
Current Respiratory Medicine Reviews Mapping the Technological Knowledge Landscape: The Case of Epigenetics
Recent Patents on Anti-Cancer Drug Discovery A New “Era” for the α7-nAChR
Current Drug Targets